287 results
Page 11 of 15
8-K
EX-99.1
c5wrxcbmun 38u
11 Feb 19
VBI Vaccines Announces Third Positive DSMB Review in Phase 1/2a Study of VBI-1901 in Recurrent GBM Patients
2:00pm
8-K
EX-99.1
8mcpz6 9kl0
16 Jan 19
VBI Vaccines Appoints Blaine McKee to Board of Directors
12:20pm
8-K
EX-99.1
0r4z23kc f76gx3jd7
20 Dec 18
VBI Vaccines Announces Phase 2 Clinical Study Design of its Prophylactic CMV Vaccine Candidate
4:10pm
8-K
EX-99.1
ite 6yq1u0e
19 Dec 18
Other Events
2:33pm
8-K
EX-99.2
5e2gq
17 Dec 18
VBI Vaccines Announces Proposed Public Offering of Common Shares
12:00am
424B5
67hvo 16z
17 Dec 18
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
7ax90z5
17 Dec 18
VBI Vaccines Announces Proposed Public Offering of Common Shares
12:00am
8-K
EX-1.1
hwfxd
17 Dec 18
VBI Vaccines Announces Proposed Public Offering of Common Shares
12:00am
424B5
xmfbn jmvq809j
12 Dec 18
Prospectus supplement for primary offering
4:17pm
8-K
EX-99.1
ch1um s4821b
6 Dec 18
VBI Vaccines Enters into License and Collaboration Agreement
8:05am
8-K
EX-99.1
wvhr6 7gi
9 Nov 18
VBI Vaccines Announces Third Quarter 2018 Financial Results and Provides Corporate Update
3:13pm
8-K
EX-99.1
nlx40vdizw7uzwubpq8
24 Oct 18
Other Events
1:42pm
8-K
EX-99.1
26j8t0dapl
16 Oct 18
Other Events
1:18pm
8-K
EX-99.1
i43qqo mz8hm6ph
4 Oct 18
VBI Vaccines’ Late-Breaker Cytomegalovirus Abstract Chosen for Oral Presentation at IDWeek
6:01am
8-K
EX-99.1
94pf00yh1vns0louxml
6 Aug 18
VBI Vaccines to Present at the Canaccord Genuity 38th Annual Growth Conference
4:29pm
8-K
EX-99.1
aqbc56aju0ag xctj
26 Jul 18
VBI Vaccines Announces Second Quarter 2018 Financial Results and Provides Corporate Update
7:49am
8-K
EX-99.1
utd25k 7s1w
19 Jun 18
VBI Vaccines to Present at 2018 JMP Securities Life Sciences Conference
8:59am